Found 18 results

2010
PROGRESS Collaborative Group, Writing Committee, Arima H, Tzourio C, Anderson C, Woodward M, Bousser MB, Macmahon S, Neal B, Chalmers J.  2010.  Effects of perindopril-based blood pressure lowering on probable cerebral amyloid angiopathy-related intracerebral hemorrhage: the PROGRESS trial. Stroke. 41 :394-6.[IF6.499].
PROGRESS Collaborative Group, Writing Committee, Arima H, Anderson C, Omae T, Liu L, Tzourio C, Woodward M, Macmahon S, Neal B et al..  2010.  Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial. Journal of Hypertension. 28 :395-400.[IF5.132].
2009
Dufouil C, Godin O, Chalmers J, Coskun O, Macmahon S, Tzourio-Mazoyer N, Bousser MG, Anderson C, Mazoyer B, Tzourio C.  2009.  Severe cerebral white matter hyperintensities predict severe cognitive decline in patients with cerebrovascular disease history. Stroke . 40:2219-21.[IF6.296]..
Joshi R , Lopez A, Macmahon S, Reddy K, Dandona R, Dandona L, Neal B.  2009.  Verbal autopsy coding . are multiple coders better than one? Bull World Health Organ. 87:51–7.[IF4.019].
Patel A, Chalmers J, Macmahon S, Neal B.  2009.  ADVANCE Blood pressure lowering in diabetes - Letter to the Editor. J Clin Hypertens (Greenwich). 11:108.[IF0].
ADVANCE Collaborative Group, Writing Committee, Ninomiya T, Perkovic V, de Galan B, Zoungas S, Pillai A, Jardine M, Patel A, Cass A et al..  2009.  Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol. 20:1813-21.[IF7.111]..
Perkovic V, Ninomiya T, Macmahon S, Chalmers J.  2009.  Chapter 9: Renal and microalbuminuria data from ADVANCE. Role of Macro and Microcirculation in Target Organ Damage in Diabetes and Hypertension.
ADVANCE Collaborative Group, de Galan BE, Zoungas S, Chalmers J, Anderson C, Dufouil C, Pillai A, Cooper M, Grobbee DE, Hackett M et al..  2009.  Cognitive function and risks of cardiovascular disease and hypoglycaemia in people with type 2 diabetes; the ADVANCE trial. Diabetelogia. 52:2329-36.[IF6.418].
ADVANCE Collaborative Group, Writing Committee, Zoungas S, de Galan BE, Ninomiya T, Grobbee D, Hamet P, Heller S, Macmahon S, Marre M et al..  2009.  The combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes; new results from ADVANCE. Diabetes Care. 32:2068-74.[IF7.349].
Brugts JJ, Ninomiya T, Boersma E, Remme W, Bertrand M, Ferrari R, Fox K, Macmahon S, Chalmers J, Simoons ML.  2009.  The consistency of the treatment effect of an ACE-inhibitor-based treatment regimen in patients with vascular disease or high-risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA and PROGRESS-trials comparing perindopril-ind. European Heart Journal. . 30:1385-94.[IF7.9].
Travakoli M, Pumford N, Woodward M, Doney A, Chalmers J, Macmahon S, MacWalter R.  2009.  An economic evaluation of a Perindopril-based blood pressure lowering regimen for patients who have suffered a cerebrovascular event. Eur J Health Econ . 10:111-9.[IF0.000]..
Joshi R, Chow C, Raju PK, Raju R, Reddy KS, Macmahon S, Lopez A, Neal B.  2009.  Fatal and nonfatal cardiovascular disease and the use of therapies for secondary prevention in a developing rural region of India. Circulation . 119 :1850-2[IF12.755].
Chow CK, Joshi R , Gottumukkala AK, Raju K, Raju R, Reddy S, Macmahon S, Neal B.  2009.  Rationale and design of the Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS): a factorial, cluster-randomized trial of 2 practical cardiovascular disease prevention strategies developed for rural Andhra Pradesh, India. American Heart Journal . 158:349-55.[IF4.285]..
Macmahon S, Yan L.  2009.  Responding to China.s hypertensive crisis. Lancet. 374:1728-9.[IF28.409].
ADVANCE Collaborative Group, de Galan BE, Perkovic V, Ninomiya T, Pillai A, Patel A, Cass A, Neal B, Poulter N, Harrap S et al..  2009.  Routine blood pressure lowering and kidney disease in type 2 diabetes. J Am Soc Nephrol. 20:883-92.[IF7.111].
2008
Chalmers J, Joshi R , Kengne AP, Macmahon S.  2008.  Blood pressure lowering with fixed combination perindopril-indapamide: key findings from ADVANCE. Proceedings of the 18th Scientific Meeting of the European Society of Hypertension (ESH). <i>Journal of Hypertension</i>. 2008;26(Supp 2):S11-S15. [IF 4.364]
Macmahon S.  2008.  Key findings of the ADVANCE Study. Proceedings of the 18th Scientific Meeting of the European Society of Hypertension (ESH) and the 22nd Scientific Meeting of the International Society of Hypertension (ISH). <i>Journal of Hypertension</i>. 2008;26(Suppl 1):S532. [IF 4.364]
Perkovic V, de Galan B, Chalmers J, Ninomiya T, Patel A, Cass A, Cooper M, Neal B, Macmahon S.  2008.  Renoprotection with perindopril-indapamide below current recommended blood pressure targets in patients with type 2 diabetes mellitus: results of the ADVANCE trial. Proceedings of the 44th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology. <i>Nephrology</i>. 2008;13(Suppl 3):A121. [IF 1.241]

Latest news

Recently added pages

Our focus

George Institute sites